Epidemiology of surgical site infections after solid organ transplants in the period 2015–2019 : A single‐center retrospective cohort study
Surgical site infections (SSI) are severe complications of solid organ transplant (SOT). This retrospective study assessed the epidemiology of and outcomes associated with invasive primary SSI (IP‐SSI) occurring within 3 months of transplantation in adult SOT recipients at Duke University over a 5‐year period (2015–2019). Among 2073 consecutive SOT recipients, 198 IP‐SSI were identified. The IP‐SSI rate declined over the period (14.4% in 2015 vs. 8.3% in 2019) and was higher among multi‐organ compared with single‐organ transplants (33.9% vs. 8.1%, p < .01). SOT recipients with IP‐SSI had longer hospital stays than patients without SSI (30.0 vs. 17.0 days, p < .01). Transplant hospitalization (9.6% vs. 2.2%, p < .01), 6‐month (11.6% vs. 3.3%, p < .01), and 1‐year mortality (15.7% vs. 5.8%, p < .01) were higher in SOT recipients with IP‐SSI than in those without. While Gram‐positive bacteria were the most common pathogens, urogenital Mollicute and atypical Mycobacteria were identified as an unexpected cause of IP‐SSI, particularly among lung transplant recipients. The median time to IP‐SSI was 24.0 (IQR 13.8–48.3) days, although the time to IP‐SSI varied based on organ transplanted and the causative pathogen. IP‐SSI is an important and potentially modifiable complication of SOT, associated with prolonged hospitalizations and reduced survival, particularly in the lung transplant population..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
American Journal of Transplantation - 22(2022), 12, Seite 3021-3030 |
| Beteiligte Personen: |
Carugati, Manuela [VerfasserIn] |
|---|
| Anmerkungen: |
© 2022 The American Society of Transplantation and the American Society of Transplant Surgeons |
|---|
| Umfang: |
10 |
|---|
| doi: |
10.1111/ajt.17189 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY001226983 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY001226983 | ||
| 003 | DE-627 | ||
| 005 | 20231111123144.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230210s2022 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/ajt.17189 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_AJT_2022_22_12.zip.xml |
| 035 | |a (DE-627)WLY001226983 | ||
| 035 | |a (WILEY)AJT17189 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Carugati, Manuela |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Epidemiology of surgical site infections after solid organ transplants in the period 2015–2019 |b A single‐center retrospective cohort study |
| 264 | 1 | |c 2022 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2022 The American Society of Transplantation and the American Society of Transplant Surgeons | ||
| 520 | |a Surgical site infections (SSI) are severe complications of solid organ transplant (SOT). This retrospective study assessed the epidemiology of and outcomes associated with invasive primary SSI (IP‐SSI) occurring within 3 months of transplantation in adult SOT recipients at Duke University over a 5‐year period (2015–2019). Among 2073 consecutive SOT recipients, 198 IP‐SSI were identified. The IP‐SSI rate declined over the period (14.4% in 2015 vs. 8.3% in 2019) and was higher among multi‐organ compared with single‐organ transplants (33.9% vs. 8.1%, p < .01). SOT recipients with IP‐SSI had longer hospital stays than patients without SSI (30.0 vs. 17.0 days, p < .01). Transplant hospitalization (9.6% vs. 2.2%, p < .01), 6‐month (11.6% vs. 3.3%, p < .01), and 1‐year mortality (15.7% vs. 5.8%, p < .01) were higher in SOT recipients with IP‐SSI than in those without. While Gram‐positive bacteria were the most common pathogens, urogenital Mollicute and atypical Mycobacteria were identified as an unexpected cause of IP‐SSI, particularly among lung transplant recipients. The median time to IP‐SSI was 24.0 (IQR 13.8–48.3) days, although the time to IP‐SSI varied based on organ transplanted and the causative pathogen. IP‐SSI is an important and potentially modifiable complication of SOT, associated with prolonged hospitalizations and reduced survival, particularly in the lung transplant population. | ||
| 700 | 1 | |a Arif, Sana |4 aut | |
| 700 | 1 | |a Sudan, Debra Lynn |4 aut | |
| 700 | 1 | |a Collins, Bradley Henry |4 aut | |
| 700 | 1 | |a Haney, John Carroll |4 aut | |
| 700 | 1 | |a Schroder, Jacob Niall |4 aut | |
| 700 | 1 | |a Reynolds, John Michael |4 aut | |
| 700 | 1 | |a Lewis, Sarah Stamps |4 aut | |
| 700 | 1 | |a Yarrington, Michael Edwards |4 aut | |
| 700 | 1 | |a Miller, Rachel Ann |4 aut | |
| 700 | 1 | |a Alexander, Barbara Dudley |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American Journal of Transplantation |g 22(2022), 12, Seite 3021-3030 |w (DE-627)WLY001211277 |x 16006143 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:12 |g pages:3021-3030 |g extent:10 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 12 |h 3021-3030 |g 10 | ||